Home » Abbott Receives Supplemental Approval for HIV-1 Viral Load Test
Abbott Receives Supplemental Approval for HIV-1 Viral Load Test
Abbott announced it received a supplemental premarket approval for its recently introduced RealTime HIV-1 viral load test.
The approval allows Abbott to market a number of enhancements to the test, including a feature that allows laboratories to perform HIV-1 viral load tests with smaller amounts (0.6 mL) of blood plasma.
The RealTime test is the most sensitive HIV-1 viral load test available and the only test of its kind validated to detect and precisely measure the common strains of HIV-1 as well as all known genetic variations of the virus, including group O, group N, and non-B subtypes, the company said.
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May